Hearscape
Therapies database

Find a therapy. Follow the evidence.

See what is being studies, who is developing it, and how far it has progressed.

Search therapy records

Search a therapy, company, target, indication, or trial ID. Narrow by approach, stage, or status, then open a record to check its sources.

More filters and sort (1 active)
3 results
AOK-1
Boehringer Ingelheim · Regenerative Medicine · Preclinical
ActiveTherapeuticStronger sources
Population
Adults · Not yet defined (preclinical)
Noise- or age-related cochlear hair-cell loss
Evidence
company
Confidence
82%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossNoise-Induced Hearing Loss
Details
FX-322 by Frequency Therapeutics
Frequency Therapeutics · Regenerative Medicine · Phase 2
DiscontinuedTherapeutic
Population
Adults · 18–65 years
Stable noise- or sudden-onset SNHL
Evidence
company
Confidence
96%
Indications
Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossSudden Sensorineural Hearing Loss
Details
FX-345 by Frequency Therapeutics
Frequency Therapeutics · Regenerative Medicine · Phase 1
DiscontinuedTherapeutic
Population
Adults · 18–67 years
Acquired 40–80 dB SNHL
Evidence
company
Confidence
95%
Indications
Hearing LossSensorineural Hearing Loss
Details

A listing is not proof of safety or effectiveness. Approval and availability may vary by indication and country.

How records are checked